All Wales Medicines Strategy Group Final Appraisal Report - Ziconotide (Prialt) for the intrathecal treatment of severe, chronic pain.
Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn
StandardStandard
All Wales Medicines Strategy Group Final Appraisal Report - Ziconotide (Prialt) for the intrathecal treatment of severe, chronic pain. / Hughes, D.; Hughes, D.A.; All Wales Strategy Group., [No Value].
2008 gol. Unknown, 2008.
2008 gol. Unknown, 2008.
Allbwn ymchwil: Llyfr/Adroddiad › Adroddiad Comisiwn
HarvardHarvard
Hughes, D, Hughes, DA & All Wales Strategy Group., NV 2008, All Wales Medicines Strategy Group Final Appraisal Report - Ziconotide (Prialt) for the intrathecal treatment of severe, chronic pain. 2008 gol., Unknown.
APA
Hughes, D., Hughes, D. A., & All Wales Strategy Group., N. V. (2008). All Wales Medicines Strategy Group Final Appraisal Report - Ziconotide (Prialt) for the intrathecal treatment of severe, chronic pain. (2008 gol.) Unknown.
CBE
Hughes D, Hughes DA, All Wales Strategy Group. NV 2008. All Wales Medicines Strategy Group Final Appraisal Report - Ziconotide (Prialt) for the intrathecal treatment of severe, chronic pain. 2008 gol. Unknown.
MLA
Hughes, D., D.A. Hughes a [No Value] All Wales Strategy Group. All Wales Medicines Strategy Group Final Appraisal Report - Ziconotide (Prialt) for the intrathecal treatment of severe, chronic pain. 2008 udg. Unknown. 2008.
VancouverVancouver
Hughes D, Hughes DA, All Wales Strategy Group. NV. All Wales Medicines Strategy Group Final Appraisal Report - Ziconotide (Prialt) for the intrathecal treatment of severe, chronic pain. 2008 gol. Unknown, 2008.
Author
RIS
TY - BOOK
T1 - All Wales Medicines Strategy Group Final Appraisal Report - Ziconotide (Prialt) for the intrathecal treatment of severe, chronic pain.
AU - Hughes, D.
AU - Hughes, D.A.
AU - All Wales Strategy Group., [No Value]
PY - 2008/1/1
Y1 - 2008/1/1
UR - http://www.wales.nhs.uk/sites3/Documents/371/ziconotide%20Prialt%20FAR.pdf
M3 - Commissioned report
BT - All Wales Medicines Strategy Group Final Appraisal Report - Ziconotide (Prialt) for the intrathecal treatment of severe, chronic pain.
PB - Unknown
ER -